Beyang Therapeutics Co., Ltd. has successfully closed an oversubscribed Series A financing round, raising nearly $30 million to advance global...
-
-
Recent Updates
- From Ore Exporter to Industry Hub: China’s Evolution in Africa
- Chery’s Expansion Signals Shift in Auto Production Strategy
- Beyang Therapeutics Secures $30 Million in Series A Financing for Drug R&D
- China Tightens Oversight on Offshore Trusts Impacting Singapore Wealth Sector
- China Confronts Looming Property Crisis Due to Expired Leases
- Chinese Automakers Shift Production to Africa Amid Global Trade Changes
- Chinese LPs Pose Compliance Challenge for Global PE Funds Despite FDI Rule Changes
- The man who built Qwen has a new lab, and the Shanghai government is an investor
- China Blocks Meta-Manus Deal Amid Tightened Investment Rules
- China-Pakistan Collaboration Deepens for Export Boosts amidst CPEC 2.0 Initiatives
Blogroll